Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour.Lenire is a treatment option for 3.2m veterans living with…
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine…
HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) -- Arialief is nutritional support specifically designed to offer sciatic nerve relief. It…
Clinical Trial Utilizing Low-Intensity Transcranial Focused Ultrasound Pulses to Key Brain Region Shows Notable Reduction in Negative Thoughts, Improved Well-being,…
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater…
Sensi brings renowned dementia and aging care expert Teepa Snow's proven strategies to the point of care—blending AI with human…
WASHINGTON, April 3, 2025 /PRNewswire/ -- The Lilabean Foundation (LBF) is playing a critical role in advancing pediatric brain cancer research…
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- “We’ve got several pro bodybuilding athletes ready and waiting to get to…
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB…
NDA Submission On-Target for Mid-2025KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing…